TCTR20210714003招募中2 期
Immunogenicity and safety of heterologous prime boost COVID-19 vaccines in Thai people.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 264
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. 18 years old or more 2. Negative urine pregnancy test (in case of potential of pregnancy) 3. No history of a severe allergic reaction to the prior vaccine. 4. No fever nor history of fever within 14 days. 5. No symptoms of respiratory tract infection within 14 days. 6. sign informed consent to the study.
排除标准
- •1. prior COVID-19 vaccination. 2. pregnancy. 3. lactation.
研究者
相似试验
已完成
不适用
TRAP VAC TRIAPaediatricsMalariaPACTR2010020001771828niversity of Oxford30
已完成
不适用
Safety of Malaria vaccines in Gambian infantsPaediatricsMalariaPACTR201401000363170niversity of Oxford36
已完成
不适用
Safety of Malaria vaccines in Gambian childrePaediatricsMalariaPACTR201204000362870niversity of Oxford36
Unknown
不适用
Safety of Malaria vaccines in Gambian adults , children and infantsMalariaPACTR201008000221638Oxford University, Jenner Institute52
招募中
4 期
Safety and Immunogenicity of heterologous or homologous booster after complete vaccination against COVID-19.Covid19D012141RBR-5y9y7p7Secretaria Municipal de Saúde do Rio de Janeiro